Academy of Breastfeeding Medicine (ABM)
Professional societyA U.S. physician membership society focused on breastfeeding medicine. · United States
Visit the source site · Audited 2026-10-14
Who pays for it
ABM's 2024 tax return reports $654,022 in revenue, including $305,303 in contributions, or 46.7%, with donor sectors unlisted; it permits reviewed, WHO Code-compliant meeting sponsors, but the amount was not verified.
Status: Labeled
ABM publishes protocol-level methods and disclosures, but permits commercial meeting support and its current ethics-code file was not available for review. SafeMomma therefore cites ABM only with a visible label.
How SafeMomma uses it
SafeMomma shows a visible professional-society label for ABM and checks each protocol's methods, date, disclosures, and disputed points against other sources.
The audit
- Who controls it
- ABM is a physician-led society; its published procedure assigns protocols to expert authors, outside reviewers, a committee, and final Board approval. That procedure dates to 2011, and the current ethics-code file could not be retrieved.
- Money
- ABM's return for the year ending December 2024 reports $654,022 in revenue and $305,303 in contributions, or 46.7%; it does not identify donor sectors or separate grants from other gifts. Meeting sponsorship and exhibit income were not verified.
- Conflict rules
- Protocol 19, revised in 2024, says its authors had no financial conflicts or funding; Protocol 36, revised in 2022, discloses an author's research and assay funding and reports no commercialization payments or royalties. The current ethics code was inaccessible, and a 2010 letter about a voluntary industry code does not confirm current enforcement.
- Method
- Protocol 19 searched six databases for 2014 to 2023 literature but says it was not a formal systematic review; it uses SORT, a system for rating evidence, and recommendation grades. ABM's 2011 procedure describes literature searches, outside review, and Board approval, but the audit did not assume that every current protocol follows it.
- Dates on its pages
- The sampled protocols were revised in 2024 and 2022; the 2011 procedure calls for five-year review, but current enforcement of that schedule was not verified.
- Political exposure
- In the reviewed 2023 Protocol 36 dispute, the disagreement concerned science and methods, not a political intervention; no politically ordered protocol removal or rewrite was found in this source pass. ABM's public WHO Code policy is an organizational policy, not evidence of government control.
- Money exposure
- ABM's 2026 meeting policy permits for-profit sponsors and exhibitors subject to review and World Health Organization Code compliance, and ABM says participation does not mean endorsement. The audit found no evidence linking commercial support to a specific protocol recommendation; donor-sector amounts and current ethics safeguards remain unverified.
- Track record
- ABM was not a source assessed in the five b1-b5 tests. Separately, the 2023 critique of Protocol 36 challenged its evidence and recommendations, and the authors defended the protocol; its listed 2022 correction was not inspected, so its content and importance remain unknown.
Where this comes from
Incentive exposure describes pressure from money or politics, not whether the source is right. Funding alone does not show influence.